Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001794

CERILLIANT™ Norbuprenorphine-D3 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Catalog No. 01001794 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-794 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-794 Supplier MilliporeSigma Supelco Supplier No. N9201ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

Norbuprenorphine is the primary active metabolite of the opiate buprenorphine in urine. This internal standard is suitable for quantitation of norbuprenorphine levels or isotope dilution methods by GC/MS or LC/MS for pain prescription monitoring, clinical toxicology, urine drug testing or forensic analysis. Buprenorphine, sold under trade names such as Buprenex™, Subutex™ and Suboxone™, is an opiate drug used to treat opioid addiction and moderate to acute pain.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 350482-19-8
Linear Formula C25H32D3NO4
MDL Number MFCD01861544
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 100 μg/mL in methanol
Synonym Norbuprenorphine-d3
Formula Weight 416.57
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.